Naltrexone versus acamprosate in the relapse prevention of alcoholism: A randomized placebo controlled trial

被引：0
|
作者：
Kiefer, F [1 ]
Jahn, H [1 ]
Briken, P [1 ]
Kampf, P [1 ]
Holzbach, R [1 ]
Naber, D [1 ]
Wiedemann, K [1 ]
机构：
[1] Univ Hamburg, Dept Psychiat, D-20246 Hamburg, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S391 / S391
页数：1
相关论文
共 50 条
  • [41] Quetiapine versus placebo in the treatment of delirium: a randomized controlled trial
    Tahir, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S358 - S358
  • [42] Prochlorperazine maleate versus placebo for the prevention of acute mountain sickness: study protocol for a randomized controlled trial
    Small, Elan
    Goldberg, Elizabeth
    Musi, Martin
    Strickland, Brian
    Paterson, Ryan
    Phillips, Caleb
    Keyes, Linda E.
    TRIALS, 2024, 25 (01)
  • [43] Acamprosate and prevention of relapse in alcoholics - Results of a randomized, placebo-controlled, double-blind study in out-patient alcoholics in the Netherlands, Belgium and Luxembourg
    Geerlings, PJ
    Ansoms, C
    vandenBrink, W
    EUROPEAN ADDICTION RESEARCH, 1997, 3 (03) : 129 - 137
  • [44] Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial
    Ghodsi, Seyedeh Zahra
    Abbas, Zaheer
    Abedeni, Robabeh
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2015, 16 (05) : 431 - 437
  • [45] Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial
    Seyedeh Zahra Ghodsi
    Zaheer Abbas
    Robabeh Abedeni
    American Journal of Clinical Dermatology, 2015, 16 : 431 - 437
  • [46] Optimal prevention of relapse among opioid users: A 12-week randomized controlled trial of extended-release naltrexone injections versus daily buprenorphine-naloxone
    Tanum, Lars Hakon
    Opheim, Arild
    Solli, Kristin
    Sharma-Haase, Kamni
    Latif, Zill-e-Huma
    Kunoe, Nikolaj
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E200 - E201
  • [47] Optimal Prevention of Relapse Among Opioid Users: A 12-Week Randomized Controlled Trial of Extended- Release Naltrexone Injections Versus Daily Buprenorphine-Naloxone
    Tanum, Lars
    Solli, Kristin
    Opheim, Arild
    Sharma-Haase, Kamni
    Latif, Huma
    Kunoe, Nikolaj
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S265 - S266
  • [48] Naltrexone for alcohol dependence: a randomized controlled trial
    Morris, PLP
    Hopwood, M
    Whelan, G
    Gardiner, J
    Drummond, E
    ADDICTION, 2001, 96 (11) : 1565 - 1573
  • [49] Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: A meta-analysis of randomized controlled trials
    Streeton, C
    Whelan, G
    ALCOHOL AND ALCOHOLISM, 2001, 36 (06): : 544 - 552
  • [50] Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy A Randomized Controlled Pilot Trial
    Finnegan, Martha
    Galligan, Toni
    Ryan, Karen
    Shanahan, Enda
    Harkin, Andrew
    Daly, Leslie
    McLoughlin, Declan M.
    JOURNAL OF ECT, 2019, 35 (02) : 115 - 121
12345